Department of Health



South Dakota Department of Health

Require that no medical abortions by use of mifepristone and misoprostol may be conducted except in a licensed abortion facility, with an observation periods, and that the pregnant woman must be informed that the effects of the medications may be reversible and require the abortion facility to collect and maintain certain information.

New content is added below as the draft rules move through the rule-making process.






Interim Rules Hearing
Important Dates
Public Hearing:
Comment Deadline:
Interim Rules Committee Hearing:
Filed-Secretary of State:
Rule Effective:
12/08/2021
12/18/2021


Agency Contact: Susan Sporrer mail to: DOHAdminRules@state.sd.us